SCHEMBL23273239

SCHEMBL23273239

CC(C)CC(N)C(=O)N1CCCC1C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(N)=O)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NTSR2 O95665 1/20 0.60
NTSR1 P30989 1/20 0.60
SORT1 Q99523 1/20 0.60
CAPN1 P07384 2/20 0.57
CTSB P07858 2/20 0.57
ERAP2 Q6P179 1/20 0.56
KISS1R Q969F8 4/20 0.55
DPP3 Q9NY33 4/20 0.54
TACR1 P25103 1/20 0.53
CXCL8 P10145 5/20 0.52
CXCR4 P61073 1/20 0.51
F13A1 P00488 1/20 0.50
TGM2 P21980 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29569487 0.88 TACR1 (0.59) NTSR2NTSR1SORT1DPP3TACR1
SCHEMBL31672180 0.88 DPP3 (0.58) NTSR2NTSR1SORT1CAPN1CTSB
SCHEMBL31499422 0.88 DPP3 (0.57) NTSR2NTSR1SORT1CAPN1CTSB
SCHEMBL29603037 0.87 CXCL8 (0.59) NTSR2NTSR1SORT1CAPN1CTSB
SCHEMBL30957019 0.87 DPP3 (0.61) NTSR2NTSR1SORT1DPP3TACR1
SCHEMBL30932912 0.87 DPP3 (0.60) NTSR2NTSR1SORT1CAPN1CTSB
SCHEMBL30051252 0.87 DPP3 (0.65) NTSR2NTSR1SORT1CAPN1CTSB
SCHEMBL31499421 0.86 DPP3 (0.60) NTSR2NTSR1SORT1CAPN1CTSB
SCHEMBL31676682 0.86 DPP3 (0.56) NTSR2NTSR1SORT1CAPN1CTSB
SCHEMBL16566032 0.86 DPP3 (0.54) NTSR2NTSR1SORT1CAPN1CTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11911451-B2 Composition of tumor-associated proliferative peptides and related anti-cancer immunogen for the treatment of lung cancers and other cancers ImmuLogix Ltd (US) 2024-02-27 US disclosed
US-20210121546-A1 COMPOSITION OF TUMOR-ASSOCIATED PROLIFERATIVE PEPTIDES AND RELATED ANTI-CANCER IMMUNOGEN FOR THE TREATMENT OF LUNG CANCERS AND OTHER CANCERS ImmuLogix Ltd (US) 2021-04-29 US disclosed